Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey
Open Access
- 1 August 2006
- Vol. 92 (8) , 1077-1083
- https://doi.org/10.1136/hrt.2005.074070
Abstract
Objective: To determine the prevalence of chronic oral anticoagulant drug treatment (COA) among patients with acute myocardial infarction (AMI) and its impact on management and outcome. Methods: All patients with ST segment elevation AMI on the RICO (a French regional survey for AMI) database were included in this analysis. COA was defined as continuous use ⩾ 48 hours before AMI. Results: Among the 2112 patients with ST elevation myocardial infarction (STEMI), 93 (4%) patients were receiving COA. These patients were older and more likely to have a history of hypertension, diabetes and prior myocardial infarction than patients without COA. In addition, fewer patients who received COA underwent reperfusion therapy or received an antiplatelet agent (aspirin/thienopyridines). Moreover, patients receiving COA experienced a higher incidence of in-hospital major adverse events (death, recurrent myocardial infarction or major bleeding, p = 0.005). Multivariate analysis showed that only ejection fraction, current smoking and multiple vessel disease, but not COA, were independent predictive factors for major adverse events. In contrast, COA was an independent predictive factor for heart failure when adjusted for age, diabetes, creatinine clearance, reperfusion, heparin and glycoprotein IIb/IIIa inhibitors (odds ratio 2.06, CI 95% 1.23 to 3.43, p = 0.005). Conclusion: In this population based registry, patients with STEMI with prior use of COA constituted a fairly large group (4%) with an overall higher baseline risk profile than that of patients without COA. Fewer in the COA group received reperfusion therapy or aggressive antithrombotic treatment and they experienced more adverse in-hospital outcomes. Thus, further studies are warranted to develop specific management strategies for this high risk group.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of ageThe American Journal of Cardiology, 2004
- Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulationAmerican Heart Journal, 2004
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2003
- Clopidogrel and warfarin: absence of interaction in patients receiving long-term anticoagulant therapy for non-valvular atrial fibrillationThrombosis and Haemostasis, 2003
- Bleeding complications with platelet glycoprotein IIb/IIIa receptor antagonistsCurrent Opinion in Hematology, 1999
- Influence of Gender on In-Hospital Clinical and Angiographic Outcomes and on One-Year Follow-Up In the New Approaches to Coronary Intervention (NACI) RegistryThe American Journal of Cardiology, 1997
- Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial InfarctionCirculation, 1997
- Peripheral vascular complications of directional coronary atherectomy and stenting: Predictors, management, and outcomeThe American Journal of Cardiology, 1994
- Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.Circulation, 1991
- Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarctionThe American Journal of Medicine, 1988